Treace Medical Concepts
Filed with the SEC on · accession 0001193125-26-450722
TMCI filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.
Treace Medical Concepts filed its quarterly 10-Q report for the period ending September 30, 2026, confirming it remains an accelerated filer with 65,559,597 shares of common stock outstanding.
✦ Ask GOAX AI about this filing — what it means for TMCI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TMCI?
Click hereTMCI filed a 10-Q (SEC filing). Treace Medical Concepts filed its quarterly 10-Q report for the period ending September 30, 2026, confirming it remains an accelerated filer with 65,559,597 shares of common stock outstanding.
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Get alerts when TMCI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days